Skip to content

Kyoji Okita

Department of Psychiatry, Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Advanced Neuroimaging, Integrative Brain Imaging Center, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Neuropsychiatry, Okayama University Hospital, Okayama, Japan. Electronic address: kokita@ncnp.go.jp.

1 paper in the library · 1 citation · publishing 2024

Papers

Potential effect of ketamine in treatment for dextromethorphan use disorder exploding in Japanese young population.

Asian journal of psychiatry September 1, 2024 Kaori Ishii, Kyoji Okita 1 citation

In Japan, more people are misusing the over-the-counter drug dextromethorphan (DXM), often to cope with severe trauma-related and mood symptoms. These patients have substance use disorders and self-medicate with DXM. Because ketamine has similar psychopharmacological effects to DXM, the authors propose that ketamine could serve as an alternative pharmacological treatment for these patients.